A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function
Status:
Recruiting
Trial end date:
2022-10-19
Target enrollment:
Participant gender:
Summary
The main aim is to check the effect of a single dose of soticlestat in adults with moderate
or severe liver failure compared to healthy adults with normal liver function.
Participants will check into the study clinic for 8 days. During the stay, one oral dose of
soticlestat will be given and the participant will be monitored. The clinic staff will follow
up with the participant about a week after discharge from the clinic.